144 0001834021 XXXXXXXX LIVE 0001650648 4D Molecular Therapeutics, Inc. 001-39782 5858 Horton Street Suite 455 Emeryville CA 94608 1-510-505-2680 David Kirn Officer Class A Common Goldman Sachs & Co. LLC 200 West Street New York NY 10282 12930 300622.5 51703412 06/24/2024 NASD Class A Common 02/10/2022 Acquired as compensation -- Stock Options Issuer N 4625 06/24/2024 Compensation -- Cashless exercise / same-day sale Class A Common 12/11/2023 Acquired as compensation -- Stock Options Issuer N 8305 06/24/2024 Compensation -- Cashless exercise / same-day sale Y The sales of shares set forth herein are made in connection with a selling plan dated 3/21/2024, that is intended to comply with Rule 10b5-1(c). 06/24/2024 03/21/2024 Goldman Sachs & Co. LLC on behalf of David Kirn